Holdings of Fidelity Disruptive Medicine ETF
Fidelity Covington Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 41M $ including 40.9M $ in equities, 99.7 %
- Positions
- 68 in 9 countries
- Top ten
- 31.4 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | UCB SA | 6,605 | 1.9M $ | 4.73 % |
| 2 | LIFESTANCE HEALTH GROUP INC | 227,100 | 1.8M $ | 4.27 % |
| 3 | Danaher Corp | 7,675 | 1.4M $ | 3.42 % |
| 4 | 10X Genomics Inc | 45,000 | 1.3M $ | 3.11 % |
| 5 | Intuitive Surgical Inc | 2,816 | 1.2M $ | 2.92 % |
| 6 | COGENT BIOSCIENCES INC | 33,428 | 1.2M $ | 2.85 % |
| 7 | ALNYLAM PHARMACEUTICALS INC | 3,791 | 1.1M $ | 2.79 % |
| 8 | Argenx SE | 1,365 | 1.1M $ | 2.78 % |
| 9 | LEGEND BIOTECH CORP | 34,614 | 940.1K $ | 2.29 % |
| 10 | UnitedHealth Group Inc | 2,424 | 921.9K $ | 2.25 % |
| 11 | Bio-Techne Corp | 17,786 | 919.2K $ | 2.24 % |
| 12 | Ascendis Pharma A/S | 3,865 | 866.2K $ | 2.11 % |
| 13 | Edwards Lifesciences Corp | 10,000 | 864.7K $ | 2.11 % |
| 14 | MODERNA INC | 18,282 | 862.7K $ | 2.11 % |
| 15 | KYMERA THERAPEUTICS INC | 10,000 | 814.2K $ | 1.99 % |
| 16 | Xenon Pharmaceuticals Inc | 14,366 | 786.3K $ | 1.92 % |
| 17 | HeartFlow Inc | 24,994 | 774.3K $ | 1.89 % |
| 18 | Sartorius Stedim Biotech | 3,633 | 754.7K $ | 1.84 % |
| 19 | Insmed Inc | 6,875 | 735K $ | 1.79 % |
| 20 | Veeva Systems Inc | 4,188 | 730.1K $ | 1.78 % |
| 21 | VAXCYTE INC | 14,071 | 723.2K $ | 1.77 % |
| 22 | REVOLUTION MEDICINES INC | 4,504 | 709.3K $ | 1.73 % |
| 23 | CARIS LIFE SCIENCES INC | 41,991 | 702.1K $ | 1.71 % |
| 24 | Crinetics Pharmaceuticals Inc | 19,000 | 675.5K $ | 1.65 % |
| 25 | Axsome Therapeutics Inc | 2,752 | 645.3K $ | 1.57 % |
| 26 | CYTOKINETICS INC | 8,262 | 634.2K $ | 1.55 % |
| 27 | Veracyte Inc | 13,621 | 631.2K $ | 1.54 % |
| 28 | Thermo Fisher Scientific Inc | 1,276 | 628.4K $ | 1.53 % |
| 29 | BRIGHTSPRING HEALTH SERVICES INC | 10,187 | 628.3K $ | 1.53 % |
| 30 | PRIVIA HEALTH GROUP INC | 28,119 | 604.8K $ | 1.48 % |
| 31 | Boston Scientific Corp | 12,185 | 588.7K $ | 1.44 % |
| 32 | NATERA INC | 2,615 | 584.1K $ | 1.43 % |
| 33 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 12,000 | 580.6K $ | 1.42 % |
| 34 | GUARDANT HEALTH INC | 4,375 | 567.4K $ | 1.38 % |
| 35 | Stryker Corp | 1,832 | 558.9K $ | 1.36 % |
| 36 | VIRIDIAN THERAPEUTICS INC | 31,100 | 548K $ | 1.34 % |
| 37 | ALIGNMENT HEALTHCARE INC | 33,378 | 511.4K $ | 1.25 % |
| 38 | Lonza Group AG | 780 | 500K $ | 1.22 % |
| 39 | Nuvalent Inc | 4,504 | 497.2K $ | 1.21 % |
| 40 | Stoke Therapeutics Inc | 15,670 | 484.4K $ | 1.18 % |
| 41 | Disc Medicine Inc | 6,926 | 481.8K $ | 1.18 % |
| 42 | Dexcom Inc | 6,533 | 481.7K $ | 1.18 % |
| 43 | Insulet Corp | 3,112 | 451.1K $ | 1.10 % |
| 44 | Eli Lilly & Co | 395 | 436.5K $ | 1.07 % |
| 45 | Enliven Therapeutics Inc | 10,703 | 423.5K $ | 1.03 % |
| 46 | CYTOMX THERAPEUTICS INC | 112,069 | 403.4K $ | 0.98 % |
| 47 | WAYSTAR HOLDING CORP | 20,187 | 401.9K $ | 0.98 % |
| 48 | IRhythm Holdings Inc | 3,471 | 395.3K $ | 0.96 % |
| 49 | Kestra Medical Technologies Ltd | 18,400 | 391.2K $ | 0.95 % |
| 50 | NEWAMSTERDAM PHARMA COMPANY NV | 11,122 | 374.6K $ | 0.91 % |
| 51 | AMYLYX PHARMACEUTICALS INC | 23,554 | 338K $ | 0.82 % |
| 52 | Roivant Sciences Ltd | 11,250 | 337.4K $ | 0.82 % |
| 53 | Align Technology Inc | 1,863 | 325.9K $ | 0.80 % |
| 54 | Repligen Corp | 2,485 | 308K $ | 0.75 % |
| 55 | ZAI LAB LTD | 15,273 | 270.2K $ | 0.66 % |
| 56 | MIRUM PHARMACEUTICALS INC | 2,191 | 222.4K $ | 0.54 % |
| 57 | Upstream Bio Inc | 24,900 | 208.2K $ | 0.51 % |
| 58 | Relay Therapeutics Inc | 12,996 | 182.6K $ | 0.45 % |
| 59 | STRUCTURE THERAPEUTICS INC | 4,628 | 182.1K $ | 0.44 % |
| 60 | ZENAS BIOPHARMA INC | 9,817 | 180.6K $ | 0.44 % |
| 61 | Viking Therapeutics Inc | 5,422 | 177.5K $ | 0.43 % |
| 62 | Procept Biorobotics Corp | 6,656 | 175.3K $ | 0.43 % |
| 63 | Janux Therapeutics Inc | 11,754 | 171.5K $ | 0.42 % |
| 64 | OUTSET MEDICAL INC | 34,000 | 166.3K $ | 0.41 % |
| 65 | MBX BIOSCIENCES INC | 5,128 | 161.4K $ | 0.39 % |
| 66 | Olema Pharmaceuticals Inc | 11,250 | 148.4K $ | 0.36 % |
| 67 | ORUKA THERAPEUTICS INC | 1,000 | 58.5K $ | 0.14 % |
| 68 | Spyre Therapeutics Inc | 300 | 22.1K $ | 0.05 % |
Sector breakdown
- Health care 33.0 %
- Technology 1.8 %
- Unattributed 65.2 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 92.2 %
- EUR 6.6 %
- CHF 1.2 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 79.7 %
- Belgium 4.7 %
- Netherlands 3.7 %
- Cayman Islands 3.0 %
- Denmark 2.1 %
- Canada 1.9 %
- France 1.8 %
- Bermuda 1.8 %
- Switzerland 1.2 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 57 | 32.6M $ | 79.69 % |
| 2 | Belgium | 1 | 1.9M $ | 4.75 % |
| 3 | Netherlands | 2 | 1.5M $ | 3.71 % |
| 4 | Cayman Islands | 2 | 1.2M $ | 2.96 % |
| 5 | Denmark | 1 | 866.2K $ | 2.12 % |
| 6 | Canada | 1 | 786.3K $ | 1.92 % |
| 7 | France | 1 | 754.7K $ | 1.85 % |
| 8 | Bermuda | 2 | 728.6K $ | 1.78 % |
| 9 | Switzerland | 1 | 500K $ | 1.22 % |
Cite this page
Titelia. "Holdings of Fidelity Disruptive Medicine ETF". https://titelia.com/en/funds/S000079688